Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Angio-oedema and urticaria associated with angiotensin converting enzyme inhibitors.

Literature DB >> 3032324

Angio-oedema and urticaria associated with angiotensin converting enzyme inhibitors.

S M Wood, R D Mann, M D Rawlins.

Abstract

Entities: Chemical Disease

Mesh：

Substances：
Enalapril
Captopril

Year: 1987 PMID： 3032324 PMCID： PMC1245098 DOI： 10.1136/bmj.294.6564.91

Source DB: PubMed Journal: Br Med J (Clin Res Ed) ISSN： 0267-0623

× No keyword cloud information.

3 in total

1. A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin.

Authors: H Y Yang; E G Erdös; Y Levin
Journal: Biochim Biophys Acta Date: 1970-08-21

2. Antihypertensive and renal effects of captopril in relation to renin activity and bradykinin-induced vasodilation.

Authors: W Kiowski; P van Brummelen; L Hulthén; F W Amann; F R Bühler
Journal: Clin Pharmacol Ther Date: 1982-06 Impact factor: 6.875

3. Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema.

Authors: M Schapira; L D Silver; C F Scott; A H Schmaier; L J Prograis; J G Curd; R W Colman
Journal: N Engl J Med Date: 1983-05-05 Impact factor: 91.245

3 in total

22 in total

1. Angioedema due to ACE inhibitors: increased risk in patients of African origin.

Authors: C R Gibbs; G Y Lip; D G Beevers
Journal: Br J Clin Pharmacol Date: 1999-12 Impact factor: 4.335

2. Role of tachykinins in enhancement of bradykinin-induced bronchoconstriction by captopril.

Authors: M Arakawa; M Majima; K Nagai; F Goto; M Katori
Journal: Inflamm Res Date: 1996-02 Impact factor: 4.575

3. Effects of intradermal bradykinin after inhibition of angiotensin converting enzyme.

Authors: R E Ferner; J M Simpson; M D Rawlins
Journal: Br Med J (Clin Res Ed) Date: 1987-05-02

4. Angio-oedema in relation to treatment with angiotensin converting enzyme inhibitors.

Authors: T Hedner; O Samuelsson; H Lunde; L Lindholm; L Andrén; B E Wiholm
Journal: BMJ Date: 1992-04-11

5. Review of yellow cards (1986): report to the Committee on the Safety of Medicines.

Authors: J L Bem; A M Breckenridge; R D Mann; M D Rawlins
Journal: Br J Clin Pharmacol Date: 1988-12 Impact factor: 4.335

Review 6. Safety profiles of the angiotensin-converting enzyme inhibitors.

Authors: N J Warner; J E Rush
Journal: Drugs Date: 1988 Impact factor: 9.546

7. A comparison of the effects of captopril and enalapril on skin responses to intradermal bradykinin and skin blood flow in the human forearm.

Authors: T C Li Kam Wa; E D Cooke; P Turner
Journal: Br J Clin Pharmacol Date: 1993-01 Impact factor: 4.335